What is the current share price of Suven Life Sciences Limited (SUVEN)?

As of the latest market update, Suven Life Sciences Limited (SUVEN) is trading at ₹268.25. The stock has moved 1.94% up in the recent session.

What is the technical sentiment for SUVEN stock?

Based on our proprietary technical analysis, the current signal for SUVEN is "BUY". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Suven Life Sciences Limited?

Suven Life Sciences Limited has seen a 52-week high of ₹299.99 and a 52-week low of ₹124.11. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Suven Life Sciences Limited belong to?

Suven Life Sciences Limited operates in the Healthcare sector, specifically within the Healthcare Services industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of SUVEN?

Suven Life Sciences Limited (SUVEN) has a market capitalization of approximately ₹6.10K Cr. This classifies it as a small cap stock in the Indian market.

SUVEN

NSE

Suven Life Sciences Limited (SMALL CAP)

Healthcare>Healthcare>Healthcare Services>Healthcare Research Analytics & Technology

₹268.25

5.10 (1.94%)

High VOLATILITY

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹6.10K Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

N/A

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Healthcare Research Analytics & Technology

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹124.11+116.1%

52W High₹299.99-10.6%

Current Price

₹268.25

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹214.60

Upper Circuit₹321.90

Reference Price

₹268.25

Investment Checklist

Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹231.23

Double Bottom on 1W (BREAKOUT CONFIRMED) — target ₹227.93

Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

Composite score 43.82 (BUY) with 48.8% confidence

10/20 Bearish Cross detected 1 day(s) ago

Technical Analysis

Analysis from 2026-06-12

Confidence

49%

Trend

BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20

255.62

EMA50

229.28

EMA200

206.4

Price Action

MIXED

NEUTRAL

Higher Highs4

Higher Lows5

Lower Highs5

Lower Lows4

Support & Resistance Levels

Resistance (Above)

₹271.72

₹298.97

Support (Below)

₹235.67

₹229.69

₹227.00

₹216.74

₹207.01

Volume Analysis

TrendDECREASING

Change-55.20%

Unusual VolumeNo

Recent MA Crossovers

10/20 Bearish Cross

1 day ago

SELL

Stop Loss Levels

Fixed Risk

1% Risk₹265.57

3% Risk₹260.20

5% Risk₹254.84

7% Risk (Custom)

₹249.47

Technical Levels

1x ATR (Volatility)₹251.10

2x ATR (Swing)₹233.95

3x ATR (Trend)₹216.80

Immediate Support₹235.67

Moving Averages

EMA 9 (Short-term)₹262.32

EMA 20 (Medium-term)₹255.62

EMA 50 (Trend)₹229.28

EMA 200 (Long-term)₹206.40

Financials

Financial Analysis

Metric	Mar '25	Jun '25	Sep '25	Dec '25
Revenue	₹1.5 Cr	₹1.9 Cr	₹91,92,000	₹2.8 Cr
Net Profit	₹-43.9 Cr	₹-51.5 Cr	₹-77.3 Cr	₹-101.9 Cr
EPS	—	₹-2.36	₹-3.48	₹-4.55
Operating Profit	₹-42.6 Cr	₹-50.1 Cr	₹-76 Cr	₹-100.6 Cr

ROE

-146.15%

ROCE

-146.11%

Debt/Equity

0.00

Current Ratio

3.21

OPM

-3580.87%

NPM

-3628.79%

Peer Comparison

Healthcare Research Analytics & Technology

Peer Comparison

Symbol	Name	Price	Change
SYNGENE	Syngene International Limited	₹458.55	+2.37%
INDGN	Indegene Limited	₹510.35	+0.71%
VIMTALABS	Vimta Labs Limited	₹554.85	+6.45%
TAKE	Take Solutions Limited	₹29.67	+0.30%
BI	Bilcare Limited	₹59.79	+0.08%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
30 Jul 2024	Annual General Meeting	AGM
02 Aug 2023	Annual General Meeting	AGM
17 Oct 2022	Rights 1:2 @ Premium Rs 54/-	RIGHTS_ISSUE
29 Jul 2022	Annual General Meeting	AGM
02 Aug 2021	Annual General Meeting	AGM

Announcements

Latest updates

View All

Date	Description	Link
12 Jun 2026	Press Release
04 Jun 2026	Press Release
29 May 2026	General Updates
19 May 2026	Spurt in Volume
18 May 2026	Spurt in Volume	-

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
13 May 2026	Board Meeting Intimation	XBRL
29 Jan 2026	Financial Results
29 Jan 2026	Board Meeting Intimation	XBRL
11 Nov 2025	Board Meeting Intimation	XBRL
11 Nov 2025	Financial Results

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for SUVEN

View All

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

positive

ET Markets - Industry 1d ago

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

Anupam Rasayan India Ltd has achieved a global first by commercialising Ethyl trifluoroacetate production using its unique continuous flow chemistry technology. This advanced method offers enhanced safety and efficiency over traditional batch processes. ETFA is a vital component for pharmaceuticals and life sciences.

ALIVUSANURASGLOBALJFLLIFEJFL-RERPGLIFESAILIFESUVENVITALChemicalsConsumer Services

Read full story

positive

LiveMint - Markets 1d ago

Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone

Anupam Rasayan India announces commercialization of ETFA production via a proprietary continuous flow chemistry platform, making it the first globally to do so. The market potential for ETFA is $500-600 million, crucial for fluorinated compounds in pharmaceuticals and life sciences.

ALIVUSANURASFOCUSJFLLIFEJFL-RERPGLIFESAILIFESUVENChemicalsConsumer Durables

Read full story

positive

Business Standard - Markets 2d ago

Analysts project up to 17% upside in healthcare stocks trading at new highs

Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.

ALIVUSAPOLLOAPOLLOHOSPASTERDMHCGHCG-REHEALTHCAREHEALTHYJFLLIFEJFL-REJLHLRPGLIFESAILIFESUVENCapital GoodsFinancial Services

Read full story

SUVEN

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Recent MA Crossovers

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for SUVEN

Anupam Rasayan becomes world's first to make ETFA using flow chemistry

Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone

Analysts project up to 17% upside in healthcare stocks trading at new highs

Frequently Asked Questions

What is the current share price of Suven Life Sciences Limited (SUVEN)?

What is the technical sentiment for SUVEN stock?

What is the 52-week high and low for Suven Life Sciences Limited?

Which sector does Suven Life Sciences Limited belong to?

What is the market capitalization of SUVEN?